[1]BioorganicandMedicinalChemistry,2012,vol.20,p.4377-4389
[1]Patent:WO2017/66742,2017,A1.Locationinpatent:Paragraph0140;0142
[2]EuropeanJournalofMedicinalChemistry,2019,vol.163,p.344-352
1245919-29-2
120-33-2
13730-55-7
14186-60-8
15012-36-9
16537-19-2
167626-65-5 | 2-(4H-1,2,4-Triazol-4-yl)benzoic acid | AA001XFN | MFCD11983265
168084-94-4 | 3-[(2-Chlorobenzyl)oxy]benzaldehyde | AA001XPI | MFCD01008627
16853-85-3 | Lithium aluminium hydride | AA001Y21 | MFCD00011075
16890-91-8 | Trans-1,4-dichlorocyclohexane | AA001YB3 | MFCD00070474
17321-80-1 | Glycine, N-(3,4-dichlorobenzoyl)- | AA001YN0 | MFCD00228361
17354-60-8 | 3-Amino-N,N-diethyl-4-methyl-benzenesulfonamide | AA001YXL | MFCD02704641
17388-39-5 | Swertiamarin | AA001Z6G | MFCD07783984
174258-39-0 | 2-(4-Trifluoromethylphenyl)-4-chloromethyl-5-methyloxazole | AA001ZH3 | MFCD09835598
174623-07-5 | Benzoic acid, 4-(5-formyl-2-thienyl)- | AA001ZQM | MFCD06740281
1750-45-4 | 5-Chloro-6-hydroxybenzo[d]oxazol-2(3H)-one | AA00200P | MFCD00143502